Market research
ESTA Establishment Labs Holdings Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 2B
- P/E ratio
- Not available
- Analyst target
- 102.4444
- Dividend yield
- Not available
- Beta
- 1.09
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- VGG312491084
- Market cap
- 2B
- P/E ratio
- Not available
- Analyst target
- 102.4444
- Dividend yield
- Not available
- Beta
- 1.09
About
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ESTA discussion.
5 years, 4 months ago
Establishment Labs Holdings Inc is currently in a long term uptrend where the price is trading 53.8% above its 200 day moving average.
From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 18.2.
Establishment Labs Holdings Inc's total revenue rose by 11.2% to $27M since the same quarter in the previous year.
Its net income has dropped by 1.6% to $-6M since the same quarter in the previous year.
Finally, its free cash flow grew by 142.9% to $2M since the same quarter in the previous year.
Based on the above factors, Establishment Labs Holdings Inc gets an overall score of 4/5.